Revenue (Tables)

9 Months Ended

Sep. 29, 2023

Revenue from Contract with Customer [Abstract]

The following tables present the Company’s revenues disaggregated by geographical region and revenue type for the three and nine-month periods ended September 29, 2023 and September 30, 2022 ($ in millions). Sales taxes and other usage-based taxes collected from customers are excluded from revenue.


	Biotechnology		Life Sciences		Diagnostics		Environmental & Applied Solutions		Total
For the Three-Month Period Ended September 29, 2023:
Geographical region:
North America(a)	$	593	$	728	$	1,054	$	599	$	2,974
Western Europe	508		356		334		269		1,467
Other developed markets(b)	78		117		105		30		330
High-growth markets(c)	485		505		761		351		2,102
Total	$	1,664	$	1,706	$	2,254	$	1,249	$	6,873

Revenue type:
Recurring	$	1,390	$	1,062	$	1,986	$	744	$	5,182
Nonrecurring	274		644		268		505		1,691
Total	$	1,664	$	1,706	$	2,254	$	1,249	$	6,873

For the Three-Month Period Ended September 30, 2022:
Geographical region:
North America(a)	$	723	$	785	$	1,397	$	575	$	3,480
Western Europe	599		314		388		240		1,541
Other developed markets(b)	71		118		122		28		339
High-growth markets(c)	660		506		772		365		2,303
Total	$	2,053	$	1,723	$	2,679	$	1,208	$	7,663

Revenue type:
Recurring	$	1,662	$	1,038	$	2,396	$	729	$	5,825
Nonrecurring	391		685		283		479		1,838
Total	$	2,053	$	1,723	$	2,679	$	1,208	$	7,663


	Biotechnology		Life Sciences		Diagnostics		Environmental & Applied Solutions		Total
For the Nine-Month Period Ended September 29, 2023:
Geographical region:
North America(a)	$	1,822	$	2,193	$	3,160	$	1,748	$	8,923
Western Europe	1,839		1,095		1,119		830		4,883
Other developed markets(b)	229		369		322		90		1,010
High-growth markets(c)	1,523		1,554		2,260		1,044		6,381
Total	$	5,413	$	5,211	$	6,861	$	3,712	$	21,197

Revenue type:
Recurring	$	4,435	$	3,205	$	6,056	$	2,210	$	15,906
Nonrecurring	978		2,006		805		1,502		5,291
Total	$	5,413	$	5,211	$	6,861	$	3,712	$	21,197

For the Nine-Month Period Ended September 30, 2022:
Geographical region:
North America(a)	$	2,303	$	2,301	$	3,938	$	1,674	$	10,216
Western Europe	1,938		982		1,365		775		5,060
Other developed markets(b)	244		366		361		92		1,063
High-growth markets(c)	2,050		1,441		2,220		1,052		6,763
Total	$	6,535	$	5,090	$	7,884	$	3,593	$	23,102

Revenue type:
Recurring	$	5,267	$	3,143	$	7,067	$	2,138	$	17,615
Nonrecurring	1,268		1,947		817		1,455		5,487
Total	$	6,535	$	5,090	$	7,884	$	3,593	$	23,102

(a) The Company defines North America as the United States and Canada.

(b) The Company defines other developed markets as Japan, Australia and New Zealand.

(c) The Company defines high-growth markets as developing markets of the world experiencing accelerated growth, over extended periods, in gross domestic product and infrastructure which include Eastern Europe, the Middle East, Africa, Latin America (including Mexico) and Asia (with the exception of Japan, Australia and New Zealand). The Company defines developed markets as all markets of the world that are not high-growth markets.